Metoclopramide in Anorexia Caused by Cancer-Associated Dyspepsia Syndrome (CADS)
- 1 June 1993
- journal article
- research article
- Published by SAGE Publications in Journal of Palliative Care
- Vol. 9 (2) , 14-18
- https://doi.org/10.1177/082585979300900203
Abstract
Anorexia is a common problem in advanced cancer, part of the cancer anorexia-cachexia syndrome. Although the etiology is multifactorial, symptoms suggestive of gastroparesis are often present in patients with cancer anorexia. We have successfully used metoclopramide, a prokinetic agent, to stimulate appetite in advanced cancer and relieve other dyspeptic symptoms associated with anorexia.Keywords
This publication has 7 references indexed in Scilit:
- Assessment of Upper Gastrointestinal Motility in the Cancer–Associated Dyspepsia SyndromeJournal of Palliative Care, 1993
- Common Symptoms in Patients with Advanced CancerJournal of Palliative Care, 1991
- Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and CachexiaJNCI Journal of the National Cancer Institute, 1990
- Effect of Metoclopramide in Diabetic GastroparesisJournal of Clinical Gastroenterology, 1985
- Tumor-associated gastroparesis: Correction with metoclopramideThe American Journal of Surgery, 1983
- Metoclopramide to Treat Gastroparesis due to Diabetes MellitusAnnals of Internal Medicine, 1982
- Gastric neuropathy in diabetes mellitus: Clinical and radiologic observationsMetabolism, 1968